Last update:

Arthritis & Rheumatism news

Arthritis & Rheumatism

A novel cinnamaldehyde nanomedicine for rheumatoid arthritis treatment

A cross-institutional research team led by the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has developed a novel cinnamaldehyde-based prodrug nanomedicine by utilizing cinnamaldehyde, a common food additive, ...

Arthritis & Rheumatism

Air pollution may affect lupus risk

New research published in Arthritis & Rheumatology indicates that chronic exposure to air pollutants may increase the risk of developing lupus, an autoimmune disease that affects multiple organs.

Arthritis & Rheumatism

World's first CAR-T cell therapy for a child with lupus

In June 2023, Uresa A. (who was 15 years old at the time) received CAR-T cells at Universitätsklinikum Erlangen. The treatment was the last resort to slow down systemic lupus erythematosus (SLE), which is a serious autoimmune ...

Arthritis & Rheumatism

FDA expands pediatric indication for Rinvoq

The U.S. Food and Drug Administration has expanded indications for AbbVie's Rinvoq (upadacitinib) to now include pediatric patients (ages 2 years and older) with polyarticular juvenile idiopathic arthritis (pJIA) and psoriatic ...

Arthritis & Rheumatism

The impact of lifestyle intervention in rheumatoid arthritis

EULAR—The European Alliance of Associations for Rheumatology—has previously made recommendations for lifestyle interventions in people with rheumatic and musculoskeletal diseases, including rheumatoid arthritis (RA). ...

Diseases, Conditions, Syndromes

New insights into the role of salivary glands in Sjögren's disease

Sjögren's disease primarily affects the salivary and lacrimal glands, resulting in tissue inflammation characterized by the formation of tertiary lymphoid structures (TLS), and a loss of glandular function—resulting in ...

Arthritis & Rheumatism

Is fish intake linked to juvenile idiopathic arthritis?

Juvenile idiopathic arthritis (JIA) results from a complex interplay of genetic and environmental factors. Past efforts to identify JIA's environmental risk factors have been restricted due to limited high-quality data and ...

Diseases, Conditions, Syndromes

Investigating novel treatment options in systemic sclerosis

EULAR, The European Alliance of Associations for Rheumatology, updated its recommendations for systemic sclerosis (SSc) in 2023. Notably, four new therapies were added that had not been included in 2017—highlighting how ...

Arthritis & Rheumatism

Tackling issues in childhood arthritis

Rheumatological diseases can affect people during childhood, the most common being juvenile idiopathic arthritis (JIA). As well as a need to generally raise awareness of childhood arthritis, there is also a crucial need to ...

Diseases, Conditions, Syndromes

Unpicking the complexity of systemic sclerosis

In 2023, The European Alliance of Associations for Rheumatology(EULAR) updated its recommendations for the treatment of systemic sclerosis (SSc), with many new inclusions around manifestations such as skin fibrosis and interstitial ...

Arthritis & Rheumatism

Encouraging cooperation in inflammatory arthritis

There is a need to improve cross-sectoral care for people with inflammatory arthritis. The Danish Centre for Expertise in Rheumatology (CeViG) at the Danish Hospital for Rheumatic Diseases in Sønderborg, Denmark, is a unique ...